Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VTGN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
VTGN
Vistagen Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
VTGN
Vistagen Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VTGN
4
—
Pherin Pharmaceuticals, Inc. (Pherin)
unlisted
supplier
—
AffaMed
unlisted
customer
—
AffaMed Therapeutics
unlisted
customer
—
Fuji Pharma
unlisted
customer
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
VTGN
Vistagen Therapeutics, Inc.
Change
0.17
▲
+4.42%
Mkt cap
$8.2M
Revenue
$1M
Q1 FY27
Revenue
$1M
FY26
LLY
ELI Lilly & Co
Change
1,368.76
▲
+0.30%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
VTGN
Vistagen Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
0.17
▲
+4.42%
Price
1,368.76
▲
+0.30%
$8.2M
Mkt cap
$1.2T
Q1 FY27
$1M
Revenue
$24.4B
Q3 FY26
FY26
$1M
Revenue
$65.2B
FY25
Change
Change
VTGN
0.17
▲
+4.42%
vs
LLY
1,368.76
▲
+0.30%
Regular session
Nov 6 '26